News
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
ANSWER: The problem isn’t that your immune system isn’t working; it’s working a little too well for your comfort but very ...
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...
In recent interviews, Health and Human Services Secretary Robert F. Kennedy Jr. has minimized the risk COVID-19 poses to kids ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
The vaccine causes your body to make a small amount of COVID protein, which your body recognizes as foreign and destroys.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results